Clinical News: Page 1611

Better together: Auto kV with iterative recon improves CCTA
By Eric Barnes
Combining automatic tube potential selection and tube current modulation with iterative reconstruction delivered consistently high-quality coronary CT angiography (CCTA) images with doses that were lower by one-third, according to a new study from Korean researchers in Radiology.
August 21, 2013
2013 08 21 16 03 38 186 Suh Combined Figure 500 20130821230956
Check the boxes: Building a dose management program
By Neomi Mullens
There is an increasing amount of discussion, legislation, and litigation surrounding radiation safety. If you think you have a robust dose management program, think again, says Neomi Mullens from Ascendian Healthcare Consulting. In this article, she checks off seven items all organizations should consider.
August 21, 2013
2013 05 31 14 24 53 75 Ascendian Logo 200
Navidea, PETNet ink manufacturing deal
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals and PETNet Solutions have signed a radiopharmaceutical manufacturing agreement.
August 20, 2013
Elekta wins clearances for Versa HD upgrade
By AuntMinnie.com staff writers
Radiation oncology firm Elekta has received the CE Mark and clearance from the U.S. Food and Drug Administration for new features for its Versa HD linear accelerator.
August 20, 2013
fMRI of brain at rest reveals early signs of Alzheimer's
By Wayne Forrest
Functional MRI (fMRI) scans of the brain at rest show disruptions in neural networks in patients with early Alzheimer's disease at about the same time as chemical markers of the disease begin to appear in cerebrospinal fluid, according to a study published online August 19 in JAMA Neurology.
August 20, 2013
CMS issues billing code for Lymphoseek
By AuntMinnie.com staff writers
The U.S. Centers for Medicare and Medicaid Services (CMS) has issued a billing code for the Lymphoseek radiopharmaceutical from Navidea Biopharmaceuticals.
August 20, 2013
MR analysis offers speedy brain tumor therapy response
By Erik L. Ridley
An advanced MR analysis method can reveal new information on blood vessel type function, enabling physicians to determine within days whether brain tumor patients are responding to antiangiogenesis therapy, according to a report published online August 18 in Nature Medicine.
August 20, 2013
2013 08 20 16 09 19 220 Vai1 2000 20130820232958
Managing BI-RADS 3 lesions; women and minorities in radiology
By Brian Casey
August 19, 2013
Nordion, AECL settle reactor lawsuits
By AuntMinnie.com staff writers
Nordion and Atomic Energy of Canada (AECL) have entered into an agreement to resolve a dispute over nuclear facilities used to produce radioisotopes.
August 19, 2013
20/20 Imaging launches new x-ray system
By AuntMinnie.com staff writers
20/20 Imaging has launched a new chiropractic digital x-ray system, called Straight Arm X-Ray.
August 19, 2013
Given gets PillCam 510(k) clearance
By AuntMinnie.com staff writers
Video-capsule developer Given Imaging has received 510(k) clearance from the U.S. Food and Drug Administration for a new version of its camera-pill technology.
August 19, 2013
Ultrasound-detected BI-RADS 3 lesions rarely malignant
By Kate Madden Yee
Breast lesions categorized as "probably benign" on supplemental screening ultrasound are rarely malignant and could be re-evaluated at 12 months rather than six -- reducing patient anxiety, follow-up exams, and unnecessary biopsies, according to a study published online in Radiology.
August 19, 2013
2013 08 19 13 00 47 511 Barr Us Breast Fig2a 400 20130819201251
Previous Page
Page 1611 of 3659
Next Page